SEARCH

SEARCH BY CITATION

References

  • 1
    Rabinovich, G. A. and Ilarregui, J. M., Conveying glycan information into T-cell homeostatic programs: a challenging role for galectin-1 in inflammatory and tumor microenvironments. Immunol. Rev. 2009. 230: 144159.
  • 2
    Liu, S. D., Whiting, C. C., Tomassian, T., Pang, M., Bissel, S. J., Baum, L. G., Mossine, V. V. et al., Endogenous galectin-1 enforces class I-restricted TCR functional fate decisions in thymocytes. Blood 2008. 112: 120130.
  • 3
    Garin, M. I., Chu, C. C., Golshayan, D., Cernuda-Morollon, E., Wait, R. and Lechler, R. I., Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. Blood 2007. 109: 20582065.
  • 4
    McHugh, R. S., Whitters, M. J., Piccirillo, C. A., Young, D. A., Shevach, E. M., Collins, M. and Byrne, M. C., CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002. 16: 311323.
  • 5
    Toscano, M. A., Commodaro, A. G., Ilarregui, J. M., Bianco, G. A., Liberman, A., Serra, H. M., Hirabayashi, J. et al., Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses. J. Immunol. 2006. 176: 63236332.
  • 6
    Perone, M. J., Bertera, S., Shufesky, W. J., Divito, S. J., Montecalvo, A., Mathers, A. R., Larregina, A. T. et al., Suppression of autoimmune diabetes by soluble galectin-1. J. Immunol. 2009. 182: 26412653.
  • 7
    Toscano, M. A., Bianco, G. A., Ilarregui, J. M., Croci, D. O., Correale, J., Hernandez, J. D., Zwirner, N. W. et al., Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat. Immunol. 2007. 8: 825834.
  • 8
    Ouellet, M., Mercier, S., Pelletier, I., Bounou, S., Roy, J., Hirabayashi, J., Sato, S. et al., Galectin-1 acts as a soluble host factor that promotes HIV-1 infectivity through stabilization of virus attachment to host cells. J. Immunol. 2005. 174: 41204126.
  • 9
    Ouyang, J., Juszczynski, P., Rodig, S. J., Green, M. R., O'Donnell, E., Currie, T., Armant, M. et al., Viral induction and targeted inhibition of galectin-1 in EBV+ posttransplant lymphoproliferative disorders. Blood 2011. 117: 43154322.
  • 10
    Liu, S. D., Tomassian, T., Bruhn, K. W., Miller, J. F., Poirier, F. and Miceli, M. C., Galectin-1 tunes TCR binding and signal transduction to regulate CD8 burst size. J. Immunol. 2009. 182: 52835295.
  • 11
    Smith, C., Beagley, L. and Khanna, R., Acquisition of polyfunctionality by Epstein-Barr virus-specific CD8+ T cells correlates with increased resistance to galectin-1-mediated suppression. J. Virol. 2009. 83: 61926198.
  • 12
    Santucci, L., Fiorucci, S., Rubinstein, N., Mencarelli, A., Palazzetti, B., Federici, B., Rabinovich, G. A. et al., Galectin-1 suppresses experimental colitis in mice. Gastroenterology 2003. 124: 13811394.
  • 13
    Liu, S., Lee, S., Cava, A. L., Motran, C., Hahn, B. and Miceli, M., Galectin-1-induced down-regulation of T lymphocyte activation protects (NZB × NZW) F1 mice from lupus-like disease. Lupus 2011. 20: 473484.
  • 14
    Rabinovich, G. A., Daly, G., Dreja, H., Tailor, H., Riera, C. M., Hirabayashi, J. and Chernajovsky, Y., Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T-cell apoptosis. J. Exp. Med. 1999. 190: 385398.
  • 15
    Wang, C. R., Shiau, A. L., Chen, S. Y., Cheng, Z. S., Li, Y. T., Lee, C. H., Yo, Y. T. et al., Intra-articular lentivirus-mediated delivery of galectin-3 shRNA and galectin-1 gene ameliorates collagen-induced arthritis. Gene. Ther. 2010. 17: 12251233.
  • 16
    Baum, L. G., Blackall, D. P., Arias-Magallano, S., Nanigian, D., Uh, S. Y., Browne, J. M., Hoffmann, D. et al., Amelioration of graft versus host disease by galectin-1. Clin. Immunol. 2003. 109: 295307.
  • 17
    Xu, G., Tu, W. and Xu, C., Immunological tolerance induced by galectin-1 in rat allogeneic renal transplantation. Int. Immunopharmacol. 2010. 10: 643647.
  • 18
    Tsang, J. Y., Tanriver, Y., Jiang, S., Xue, S. A., Ratnasothy, K., Chen, D., Stauss, H. J. et al., Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice. J. Clin. Invest. 2008. 118: 36193628.
  • 19
    Delfs, M. W., Furukawa, Y., Mitchell, R. N. and Lichtman, A. H., CD8+ T-cell subsets TC1 and TC2 cause different histopathologic forms of murine cardiac allograft rejection. Transplantation 2001. 71: 606610.
  • 20
    Yuan, X., Ansari, M. J., D'Addio, F., Paez-Cortez, J., Schmitt, I., Donnarumma, M., Boenisch, O. et al., Targeting Tim-1 to overcome resistance to transplantation tolerance mediated by CD8 T17 cells. Proc. Natl. Acad. Sci. USA 2009. 106: 1073410739.
  • 21
    Palmowski, M. J., Gileadi, U., Salio, M., Gallimore, A., Millrain, M., James, E., Addey, C. et al., Role of immunoproteasomes in cross-presentation. J. Immunol. 2006. 177: 983990.
  • 22
    Stowell, S. R., Karmakar, S., Stowell, C. J., Dias-Baruffi, M., McEver, R. P. and Cummings, R. D., Human galectin-1, -2, and -4 induce surface exposure of phosphatidylserine in activated human neutrophils but not in activated T cells. Blood 2007. 109: 219227.
  • 23
    Vokaer, B., Van Rompaey, N., Lemaitre, P. H., Lhomme, F., Kubjak, C., Benghiat, F. S., Iwakura, Y. et al., Critical role of regulatory T cells in Th17-mediated minor antigen-disparate rejection. J. Immunol. 2010. 185: 34173425.
  • 24
    Ilarregui, J. M., Croci, D. O., Bianco, G. A., Toscano, M. A., Salatino, M., Vermeulen, M. E., Geffner, J. R. et al., Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat. Immunol. 2009. 10: 981991.
  • 25
    Kapp, J. A., Honjo, K., Kapp, L. M., Goldsmith, K. and Bucy, R. P., Antigen, in the presence of TGF-beta, induces upregulation of FoxP3gfp+ in CD4+ TCR transgenic T cells that mediate linked suppression of CD8+ T-cell responses. J. Immunol. 2007. 179: 21052114.
  • 26
    Poirier, F. and Robertson, E. J., Normal development of mice carrying a null mutation in the gene encoding the L14 S-type lectin. Development 1993. 119: 12291236.
  • 27
    Wells, J. W., Cowled, C. J., Farzaneh, F. and Noble, A., Combined triggering of dendritic cell receptors results in synergistic activation and potent cytotoxic immunity. J. Immunol. 2008. 181: 34223431.